2012
DOI: 10.3109/00016357.2012.734404
|View full text |Cite
|
Sign up to set email alerts
|

Clinical changes in periodontal subjects with the probioticLactobacillus reuteriProdentis: A preliminary randomized clinical trial

Abstract: These data indicate that oral administration of Lactobacillus reuteri Prodentis improved the short-term clinical outcomes in non-smoking patients with initial-to-moderate chronic periodontitis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

12
109
1
13

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 95 publications
(135 citation statements)
references
References 34 publications
12
109
1
13
Order By: Relevance
“…The studies of Della Riccia et al [27] and Shah et al [23] also had an unclear risk of bias in blinding of patients, as well as the researchers, and outcome assessment. One study was classified as having an unclear risk of bias for the "incomplete outcome data" parameter [28], as the authors did not report the reason/s for excluding patients data from the analysis.…”
Section: Risk Of Bias Within Studiesmentioning
confidence: 99%
See 2 more Smart Citations
“…The studies of Della Riccia et al [27] and Shah et al [23] also had an unclear risk of bias in blinding of patients, as well as the researchers, and outcome assessment. One study was classified as having an unclear risk of bias for the "incomplete outcome data" parameter [28], as the authors did not report the reason/s for excluding patients data from the analysis.…”
Section: Risk Of Bias Within Studiesmentioning
confidence: 99%
“…The study of Della Ricca et al [27] was classified as doubleblinded by the authors, however its veracity appeared questionable as no placebo group was used. A total of ten studies were placebo-controlled [16][17][18]22,[28][29][30][31][32][33], whilst the remainder were paired-comparison studies [23,27]. Both parallel [16,17,22,[28][29][30]33] and split-mouth designs [29] were identified within the RCTs.…”
Section: Study Characteristicsmentioning
confidence: 99%
See 1 more Smart Citation
“…Geralmente, são consumidos dois comprimidos por dia durante três semanas, após a RAR. Estudos demonstram a redução dos principais desfechos avaliados, como PS, índices gengival, de placa e sangramento 29 , além da redução de necessidade de cirurgia, principalmente nas bolsas de PS médias e profundas 7,30 ; também promovem redução dos níveis de MMP-8 e incremento do TIMP-1 no fluido do sulco gengival 31,32 , bem como a redução do nível dos patógenos Aggregibacter actinomycetemcomitans, Porphyromonas gingivalis e Prevotella intermedia 33 . Em uma revisão sistemática 28 a respeito da influência dos probióticos adjuntos a RAR em pacientes com periodontite crônica, avaliando quatro estudos por meta-análise, os resultados clínicos foram estatisticamente significantes para o ganho de inserção clínica, média de ganho geral (MGG): 0,42 mm, p: 0,002, e redução do sangramento a sondagem MGG: 14,66, p: 0,003, no grupo que consumiu tabletes de probióticos L. reuteri e RAR.…”
Section: Periodontiteunclassified
“…The bacteria most frequently used as probiotic are L. reuteri (DSM 17938 + ATCC PTA 5289) [72,[118][119][120], Lactibacillus salivarius WB21 [121,122], L. reuteri (ATCC 55730 + ATCC PTA 5289) [123], L. reuteri (ATCC PTA 5289) [61], Streptoccus oralis KJ3 + Streptococcus uberis KJ2 + Streptoccus rattus JH145 [124] and L. rhamnosus SP1 [125].…”
Section: Probiotics and Periodontitismentioning
confidence: 99%